Heart Disease News and Research

Latest Heart Disease News and Research

Centracare chooses Merge's iConnect for image interoperability, informatics strategy

Merge Healthcare, a leading provider of enterprise imaging and interoperability solutions, today announced that Centracare Health System's St. Cloud Hospital, the largest healthcare provider in the St. Cloud, MN region, has selected Merge's iConnect VNA (vendor neutral archive) and iConnect Share for their image interoperability and informatics strategy.

31 Oct 2011

COPCP chooses eClinicalWorks comprehensive EHR solution

eClinicalWorks, a market leader in ambulatory clinical systems, today announced that Central Ohio Primary Care Physicians (COPCP), the second largest privately-owned primary care group in the United States, has chosen eClinicalWorks comprehensive electronic health records (EHR) solution for its 230 physicians across 44 practices.

31 Oct 2011

Toshiba’s Infinix DP-i cardiovascular X-ray system to be used in eight live cases

Enabling clinicians to seamlessly transition between cardiac and peripheral intervention during a single procedure, Infinix DP-i cardiovascular X-ray system from Toshiba America Medical Systems, Inc. will be used in eight live cases at Peripheral Angioplasty and All That Jazz conference, Oct. 31 - Nov. 2, 2011, New Orleans.

31 Oct 2011

EarlySense to launch contact-free patient monitoring system in Europe

EarlySense announced today that the Company will launch its contact-free patient monitoring system in Europe at MEDICA in Duesseldorf, November 16 - 20, 2011.

31 Oct 2011

Researchers shed light on inner workings of endocycle

An international team of researchers led by investigators in the U.S. and Germany has shed light on the inner workings of the endocycle, a common cell cycle that fuels growth in plants, animals and some human tissues and is responsible for generating up to half of the Earth's biomass.

31 Oct 2011

New library for development of targeted cancer drugs

In a technical tour de force, scientists at Fox Chase Cancer Center have cataloged and cross-indexed the actions of 178 candidate drugs capable of blocking the activity of one or more of 300 enzymes, including enzymes critical for cancer and other diseases. Additionally, a free library of the results has been made available online to the research community. This unique library represents an important new tool for accelerating the development of an entire class of targeted cancer drugs.

31 Oct 2011

Scientists discover how toxic form of htt protein causes Huntington's symptoms

Scientists at the Gladstone Institutes have discovered how a form of the protein linked to Huntington's disease influences the timing and severity of its symptoms, offering new avenues for treating not only this disease, but also a variety of similar conditions.

31 Oct 2011

Medtronic’s atrial fibrillation device fails to impress safety panel

The US health advisers rejected a Medtronic Inc. device for treating atrial fibrillation, a heart rhythm disorder that is a major cause of stroke, citing risks to safety. The panel voted 8-2 that risks of device outweigh benefits of the Medtronic Cardiac Ablation System especially given the high number of strokes among patients who got the device during clinical trials.

From Medtronic 30 Oct 2011

Python heart holds surprises that could be of use in cardiology

The expanding hearts of pythons have intrigued researchers. Leslie Leinwand - a University of Colorado at Boulder molecular biologist who studies heart disease in humans called pythons’ expanding hearts “amazing biology”. “They're not swelling up. They're building (heart) muscle,” he said.

30 Oct 2011

'Deep sequencing' technology identifies new target area for depression

Scientists at the Texas Biomedical Research Institute and Yale University have identified a new target area in the human genome that appears to harbor genes with a major role in the onset of depression.

29 Oct 2011

Study uncovers mTOR's complex signaling pathway

Even yeast understand austerity. A finely tuned system evolved early on to help cells survive in a world where good times come as fast as they go. The system, a molecular switch found in organisms from yeast to humans, involves a nutrient-sensing protein that turns growth on in times of plenty and shuts it off when times are lean.

29 Oct 2011

Glitazone treatment does not cause side effects in patients with metastatic thyroid cancer

Repeated radio-ablation therapy with iodine-131 to treat metastatic thyroid cancer can be less effective than the initial round of treatment due to de-differentiation of the cancer cells as the disease progresses, making them less sensitive to I-131.

29 Oct 2011

VUMC doctors to begin statin drug screening for rare genetic variation

Vanderbilt University Medical Center doctors announced today they will begin screening patients who take commonly prescribed statin drugs for a rare genetic variation that can increase risks for side effects from these drugs such as muscle aches, kidney damage and even death.

29 Oct 2011

Researchers uncover biochemical signals that trigger generation of new lung alveoli

Researchers at Weill Cornell Medical College say they have taken an important step forward in their quest to "turn on" lung regeneration -- an advance that could effectively treat millions of people suffering from respiratory disorders.

29 Oct 2011

More than 50,000 patients at high risk of SCA have been prescribed ZOLL's LifeVest

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that more than 50,000 patients at high risk of sudden cardiac arrest (SCA) have been prescribed the LifeVest Wearable Defibrillator.

29 Oct 2011

Study: Reduced secretion of beta-amyloid signals beginning of Alzheimer's

For decades the amyloid hypothesis has dominated the research field in Alzheimer's disease. The theory describes how an increase in secreted beta-amyloid peptides leads to the formation of plaques, toxic clusters of damaged proteins between cells, which eventually result in neurodegeneration. Scientists at Lund University, Sweden, have now presented a study that turns this premise on its head.

29 Oct 2011

Sorin Group third quarter revenues decrease 2.1% to €171.4 million

Sorin Group: Revenues of €171.4 million, a 2.1% decline (-4.9% as reported) over the same period last year.

29 Oct 2011

Third Annual Translational Cancer Medicine Symposium to be held on Dec. 2

The University of Hawaii Cancer Center and The Queen's Medical Center (QMC) will host an international symposium on Friday, December 2, 2011 from 8:15 a.m. - 4:30 p.m. at The Queen's Conference Center Auditorium to discuss new information related to the recent discovery of the BAP1 genetic mutation and its link to mesothelioma, melanoma and potentially other cancers.

29 Oct 2011

Meriter to join Wisconsin Heart & Vascular Institute

Effective January 1, 2012, Wisconsin Heart & Vascular Institute will join Meriter Medical Group. The practice, which includes 16 cardiologists, vascular surgeons and mid-level providers who are highly trained specialists with experience in all areas of cardiovascular care, will be renamed Meriter Wisconsin Heart. Meriter Medical Group will thus have grown from 68 providers to 116 in less than 2 years, an increase of 71%.

29 Oct 2011

Preventive use of ACZ may reduce risk of severe high altitude illness

Measuring specific, exercise-related responses can help physicians determine who may be more at risk for severe high altitude illness (SHAI), according to a study conducted by researchers in France. The researchers also found that taking acetazolamide (ACZ), a drug frequently prescribed to prevent altitude illness, can reduce some of the risk factors associated with SHAI.

29 Oct 2011